Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PROCEPT BioRobotics Corpo...

    NASDAQ: PRCT · Real-Time Price · USD
    58.17
    -0.76 (-1.29%)
    At close: Jun 25, 2025, 3:59 PM
    58.12
    -0.09%
    After-hours: Jun 25, 2025, 07:26 PM EDT

    PROCEPT BioRobotics Statistics

    Share Statistics

    PROCEPT BioRobotics has 55.33M shares outstanding. The number of shares has increased by 6.6% in one year.

    Shares Outstanding

    n/a
    		 55.33M

    Shares Change (YoY)

    n/a
    		 6.6%

    Shares Change (QoQ)

    n/a
    		 0.78%

    Owned by Institutions (%)

    n/a
    		 96.78%

    Shares Floating

    n/a
    		 52.6M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,164

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 6.1M, so 11.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.1M

    Short % of Shares Out

    n/a
    		 11.13%

    Short % of Float

    n/a
    		 14.99%

    Short Ratio (days to cover)

    n/a
    		 7.13

    Valuation Ratios

    The PE ratio is -45.91 and the forward PE ratio is -57. PROCEPT BioRobotics's PEG ratio is 2.1.

    PE Ratio

    n/a
    		 -45.91

    Forward PE

    n/a
    		 -57

    PS Ratio

    n/a
    		 18.7

    Forward PS

    n/a
    		 4.7

    PB Ratio

    n/a
    		 10.43

    P/FCF Ratio

    n/a
    		 -40.5

    PEG Ratio

    n/a
    		 2.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for PROCEPT BioRobotics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.07, with a Debt / Equity ratio of 0.2.

    Current Ratio

    n/a
    		 9.07

    Quick Ratio

    n/a
    		 8.01

    Debt / Equity

    n/a
    		 0.2

    Debt / EBITDA

    n/a
    		 -0.98

    Debt / FCF

    n/a
    		 -0.77

    Interest Coverage

    n/a
    		 -23.09

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $296,955.03

    Profits Per Employee

    n/a
    		 $-120,916.67

    Employee Count

    n/a
    		 756

    Asset Turnover

    n/a
    		 0.42

    Inventory Turnover

    n/a
    		 1.56

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 0.22% in the last 52 weeks. The beta is 1.09, so PROCEPT BioRobotics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.09

    52-Week Price Change

    n/a
    		 0.22%

    50-Day Moving Average

    n/a
    		 56.96

    200-Day Moving Average

    n/a
    		 71.38

    Relative Strength Index (RSI)

    n/a
    		 48.63

    Average Volume (20 Days)

    n/a
    		 989,122

    Income Statement

    In the last 12 months, PROCEPT BioRobotics had revenue of 224.5M and earned -91.41M in profits. Earnings per share was -1.75.

    Revenue

    n/a
    		 224.5M

    Gross Profit

    n/a
    		 137.1M

    Operating Income

    n/a
    		 -96.61M

    Net Income

    n/a
    		 -91.41M

    EBITDA

    n/a
    		 -82M

    EBIT

    n/a
    		 -87.23M

    Earnings Per Share (EPS)

    n/a
    		 -1.75
    Full Income Statement

    Balance Sheet

    The company has 333.73M in cash and 80.25M in debt, giving a net cash position of 253.47M.

    Cash & Cash Equivalents

    n/a
    		 333.73M

    Total Debt

    n/a
    		 80.25M

    Net Cash

    n/a
    		 253.47M

    Retained Earnings

    n/a
    		 -545.99M

    Total Assets

    n/a
    		 519.38M

    Working Capital

    n/a
    		 413.73M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -99.21M and capital expenditures -4.41M, giving a free cash flow of -103.62M.

    Operating Cash Flow

    n/a
    		 -99.21M

    Capital Expenditures

    n/a
    		 -4.41M

    Free Cash Flow

    n/a
    		 -103.62M

    FCF Per Share

    n/a
    		 -1.99
    Full Cash Flow Statement

    Margins

    Gross margin is 61.07%, with operating and profit margins of -43.04% and -40.72%.

    Gross Margin

    n/a
    		 61.07%

    Operating Margin

    n/a
    		 -43.04%

    Pretax Margin

    n/a
    		 -40.72%

    Profit Margin

    n/a
    		 -40.72%

    EBITDA Margin

    n/a
    		 -36.52%

    EBIT Margin

    n/a
    		 -43.04%

    FCF Margin

    n/a
    		 -46.16%

    Dividends & Yields

    PRCT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PRCT is $95, which is 61.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $95

    Price Target Difference

    n/a
    		 61.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 13.55

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist